Comparative Effectiveness Research: A Roadmap to Sail the Seas of IBD Therapies

The drug pipeline for the treatment of inflammatory bowel disease (IBD) has dramatically expanded over the last two decades, and it is expected to further grow in the upcoming years with the introduction of new agents with different mechanisms of action. However, such an increase of therapeutic opti...

Descripción completa

Detalles Bibliográficos
Autores principales: Pugliese, Daniela, Onali, Sara, Privitera, Giuseppe, Armuzzi, Alessandro, Papi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697479/
https://www.ncbi.nlm.nih.gov/pubmed/36431194
http://dx.doi.org/10.3390/jcm11226717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697479/
https://www.ncbi.nlm.nih.gov/pubmed/36431194
http://dx.doi.org/10.3390/jcm11226717

Ejemplares similares